Top Medical News from Across Medscape

  • EMA Panel Likes Breast and Kidney Cancer DrugsThe Committee for Medicinal Products for Human Use recommended approval of ribociclib for advanced HER+/HER2- breast cancer and tivozanib for advanced renal cell carcinoma.
  • Hodgkin's Tx Intensity Can Be Spared With Negative PETPatients with advanced Hodgkin's lymphoma who show early metabolic response on FDG-PET scans can safely and effectively be switched to a reduced chemotherapy regimen, say researchers.

Business of Medicine

  • The War Over MOC Heats Up In at least 17 states, doctors are battling the American Board of Medical Specialties, hospitals, and insurers in an effort to make maintenance of certification optional. Here's how it's going.
  • A Hospital Gets Sued for Keeping a Patient Alive   Hospital clinicians who don't follow a patient's advance healthcare directive are at risk of being sued.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California